Company Profile

20/20 GeneSystems Inc (AKA: 20/20 Genomics)
Profile last edited on: 10/31/22      CAGE: 3J7E8      UEI: MPZGJ8XE8B69

Business Identifier: Using machine learning algorithms to support development of lood tests for early detection of cancers
Year Founded
2000
First Award
2003
Latest Award
2014
Program Status
Inactive
Popularity Index
Is this YOUR Company?
Ensure accuracy and completeness of YOUR Company Profile by completing the brief Survey Instrument attached
Do you know about this Awardees?
Let us encourage you to provide any data which would enhance the completeness of this firm's profile.

Location Information

9430 Key West Avenue
Rockville, MD 20850
   (240) 453-6339
   info@biocheckinfo.com
   www.2020gene.com
Location: Single
Congr. District: 08
County: Montgomery

Public Profile

20/20 GeneSystems Inc. is a molecular diagnostics company developing protein analysis biomarkers that aid in early detection and therapy selection of cancer diseases. The firm's patented platform technology for measuring biomarkers in tumors combines the visual advantages of classical pathology with the multiplex capabilities needed as a result of genomics and proteomics. Technology is now being used to develop tests to predict responses to several new targeted therapies for kidney and lung cancer. 20/20 has a working relationship with Ortho Clinical Diagnostics (“OCD”) (a Johnson & Johnson company) on a product for screening smokers and former smokers to pre-select patient population to receive annual CT scanninglung cancer becomes symptomatic. 20/20 is developing technologies to help in the detection of biological toxi

Extent of SBIR involvement

User Avatar

Synopsis: Awardee Business Condition

Employee Range
1-4
Revenue Range
Less than .5M
VC funded?
Yes
Public/Private
Privately Held
Stock Info
----
IP Holdings
20-24

Awards Distribution by Agency

Most Recent SBIR Projects

Key People / Management

  Jonathan Cohen -- President and CEO

  Timothy A Barbari

  Barry Cohen -- Director Of Sales

  Alexendrine Derrien-Colemyn

  Alysa Dortort -- Investor Relations & Sales

  John Gillespie -- Medical Affairs

  Edward A Hirschowitz

  William M James -- Research & Development

  Nada H Khattar

  Vlado Knezevic -- Senior Vice President and Chief Operating Officer

  Michael Lebowitz -- Director of R & D

  Elizabeth (Liz) Marcus -- Director of Marketing and Product Commercialization

  Gerard (Jerry) Troy -- Operations & Finance

  Peter Tunon -- Director, Marketing and Business Development